WC
BDSI

Wexford Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Wexford Capital’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-412,402
Closed -$3.48M – 217
2014
Q1 		$3.48M Buy
+412,402
New +$3.33M 0.26% 67

Other funds holding BDSI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wexford Capital's BDSI Position: Q2 2014 in Review

Wexford Capital sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2014, closing a stake of 412,402 shares — an estimated $3.48M sold.

Wexford Capital first reported a position in BDSI in Q1 2014 and held it in 1 quarter. The position peaked at $3.48M in Q1 2014. 112 funds tracked by Wall St. Rank hold BDSI as of Q2 2014.

  • Wexford Capital reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2014 after selling out during the quarter.
  • Wexford Capital sold 412,402 BioDelivery Sciences International, Inc. shares in Q2 2014, an estimated $3.48M.
  • Wexford Capital first reported a position in BioDelivery Sciences International, Inc. in Q1 2014 and held it in 1 quarter.
  • Wexford Capital's BioDelivery Sciences International, Inc. position peaked at $3.48M in Q1 2014.
  • 112 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2014.

Based on Wexford Capital's 13F filing for Q2 2014, filed 13 Aug 2014.